News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • CFTC to prioritize enforcement on insider trading in prediction markets, energy-market manipulation, spoofing, and AML violations.
  • Microsoft in exclusive talks with Chevron and Engine No. 1 on a $7 billion West Texas gas-fired power project to supply data centers.
  • Trump says U.S. could wind down attacks on Iran within weeks as fighting continued and Iran named U.S.-linked companies for targeting.
  • Wisconsin court dismissed a challenge to the congressional map, deferring redraw authority to the state supreme court.
  • Federal judge refused to approve an IRS settlement permitting houses of worship to endorse candidates, leaving the Johnson Amendment restriction in place.
  • Low Pay Commission proposes roughly 3.7% UK minimum wage rise for 2027, flagging higher labor costs for employers.
  • Fonterra removed '100% grass-fed' labeling and settled a Greenpeace suit after acknowledging the claim could mislead shoppers.

Latest Articles

Fed minutes may clarify why policymakers paused rate cuts as risks shift

Fed minutes may clarify why policymakers paused rate cuts as risks shift

Minutes from the Federal Reserve's January 16-17 policy meeting, to be published Wednesday at 2 p.m. EST, are expected to shed light on why officials chose to keep the target federal funds rate at 3.5% to 3.75% and what evidence would be required to justify further reductions. The record will likely illuminate how policymakers are balancing a job m…

U.S. futures rise as technology stocks recover and investors await Fed minutes

U.S. futures rise as technology stocks recover and investors await Fed minutes

U.S. stock futures climbed Wednesday as technology shares rebounded and investors prepared for release of minutes from the Federal Reserve’s January policy meeting. Strong premarket moves in megacap names, a multi-year Nvidia agreement with Meta, and mixed corporate results shaped trading, while markets remained alert to inflation data and evolving…

Goldman Sachs Elevates Snam to Buy as It Anticipates €14 Billion Capex Plan and Near-10% Upside

Goldman Sachs Elevates Snam to Buy as It Anticipates €14 Billion Capex Plan and Near-10% Upside

Goldman Sachs upgraded Snam to a 'buy' rating from 'neutral' and lifted its 12-month price objective to €6.90 from €6.50, signaling about 9.7% upside versus Snam's €6.29 close on Feb. 16. The brokerage expects a larger five-year capital expenditure program of roughly €14 billion for 2026-2030, driven by changes in Italy's gas import routes and the …

Alphabet: Buy the Dip on CapEx That’s Building Tomorrow’s Moat

Alphabet: Buy the Dip on CapEx That’s Building Tomorrow’s Moat

Alphabet is trading below key moving averages after a capex-driven pullback that scared short-term holders. Fundamentals - $73.3B free cash flow, $3.66T market cap, low leverage - support a long trade sized to a clear stop. Entry $305.00, target $350.00, stop $290.00 for a 180-trading-day trade that assumes capex converts into higher scale and dura…

ECB Executive Board Member Sees No Sign of Early Departure by Lagarde

ECB Executive Board Member Sees No Sign of Early Departure by Lagarde

European Central Bank Executive Board member Piero Cipollone said he had "no news" indicating President Christine Lagarde intends to leave before the scheduled end of her term. Cipollone made the remarks at a meeting of Italy's banking association, responding to press reports that Lagarde may step down ahead of the 2027 French presidential election…

Citizens Stands by $300 Target for Reddit as Ad Revenue Momentum Persists

Citizens Stands by $300 Target for Reddit as Ad Revenue Momentum Persists

Citizens reiterated a Market Outperform rating and a $300 price target on Reddit (RDDT), citing continued strength in advertising revenue and several upcoming product and monetization catalysts. The firm sees upside exceeding 115% from current levels and highlights valuation metrics and buybacks as supportive, even as other brokers issue a mix of l…

Citizens Keeps Market Outperform Rating on CareTrust REIT After 2026 Guidance and Strong Acquisition Activity

Citizens Keeps Market Outperform Rating on CareTrust REIT After 2026 Guidance and Strong Acquisition Activity

Citizens reiterated a Market Outperform rating and a $40.00 price target on CareTrust REIT (CTRE) after the company provided 2026 guidance for Normalized FAD per share of $1.90 to $1.95. CareTrust is trading near its 52-week high following a year of heavy acquisition activity and strong revenue growth, though its 2026 guidance landed slightly below…

Yardeni Analysts Say AI-Driven Market Bubble Now 'Much Less Likely'

Yardeni Analysts Say AI-Driven Market Bubble Now 'Much Less Likely'

Summary: Analysts at Yardeni Research, including Ed Yardeni, argue that the risk of an AI-fueled stock market bubble has diminished. They point to a drop in the forward price-to-earnings ratio for the S&P 500 Information Technology sector, a rotation away from the so-called Magnificent 7, and a reallocation of capital toward overseas markets. At th…

Bayer Eyes $7.25 Billion Glyphosate Deal as Shares Drop Over 8%

Bayer Eyes $7.25 Billion Glyphosate Deal as Shares Drop Over 8%

Bayer revealed a proposed $7.25 billion class settlement intended to resolve the bulk of U.S. glyphosate claims and announced additional agreements that raise total legal provisions to 11.8 billion euros. The plan, which would spread payments over as long as 21 years with heavier payments in 2026-2031, sent the stock down more than 8%. The deal rem…

Anktiva Momentum: A Swing Trade Plan for ImmunityBio (IBRX)

Anktiva Momentum: A Swing Trade Plan for ImmunityBio (IBRX)

ImmunityBio has a clearer regulatory path for ANKTIVA and expanding product revenue that justify a risk-on swing trade. The company still carries high valuation, negative cash flow, heavy short interest and legal overhangs. This trade targets upside into renewed regulatory progress while capping loss if momentum reverses.

A Decade After Paris: New Data Shows Accelerating Warming and Rising Seas

A Decade After Paris: New Data Shows Accelerating Warming and Rising Seas

New global datasets indicate the planet is warming faster since the mid-2010s, with 2025 among the three hottest years recorded. Atmospheric concentrations of carbon dioxide, methane and nitrous oxide hit record highs, global fossil fuel CO2 emissions are projected to reach a record 38.1 billion tonnes in 2025, and oceans set new highs for heat con…

Berenberg Lowers Unilever Rating, Says Turnaround Already Priced In

Berenberg Lowers Unilever Rating, Says Turnaround Already Priced In

Berenberg has cut its recommendation on Unilever Plc from buy to hold, arguing the consumer goods group's multi-year restructuring and recent operational improvements are largely captured in the current share price. The bank reduced its FY26 EPS forecast slightly following Unilever's full-year 2025 results, while highlighting stronger-than-expected…